| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.39M | 27.33M | 22.72M | 19.74M | 19.76M | 11.52M |
| Gross Profit | 11.71M | 11.27M | 8.84M | 7.03M | 7.76M | 4.30M |
| EBITDA | 2.39M | 2.11M | -2.26M | -27.09K | 3.21M | -551.96K |
| Net Income | 1.57M | 1.63M | -1.69M | -452.46K | 2.37M | -624.71K |
Balance Sheet | ||||||
| Total Assets | 30.56M | 29.49M | 25.91M | 27.37M | 27.63M | 17.51M |
| Cash, Cash Equivalents and Short-Term Investments | 1.23M | 2.06M | 1.57M | 944.73K | 8.90M | 1.16M |
| Total Debt | 6.40M | 1.88M | 2.03M | 1.24M | 1.27M | 1.32M |
| Total Liabilities | 9.26M | 6.35M | 5.21M | 4.60M | 5.35M | 8.17M |
| Stockholders Equity | 21.30M | 23.13M | 20.69M | 22.75M | 22.27M | 9.34M |
Cash Flow | ||||||
| Free Cash Flow | -5.40M | 208.92K | 644.99K | -8.45M | -2.48M | -1.24M |
| Operating Cash Flow | -5.16M | 301.78K | 833.77K | -8.21M | -2.22M | -1.06M |
| Investing Cash Flow | -247.06K | -52.86K | -138.38K | -242.76K | -253.40K | -178.02K |
| Financing Cash Flow | 2.35M | -214.74K | -14.42K | 41.93K | 10.46M | 205.15K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | C$47.87M | 30.44 | 7.33% | ― | 41.93% | ― | |
66 Neutral | C$1.69B | 63.33 | 6.07% | ― | 3.78% | -54.87% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | C$109.22M | -283.93 | -0.06% | ― | -1.95% | -102.54% | |
52 Neutral | C$123.13M | -4.00 | -19.60% | ― | 4.87% | -1195.39% | |
51 Neutral | C$45.63M | -28.69 | -9.12% | ― | 18.89% | -19.61% | |
46 Neutral | C$32.32M | 158.88 | 1.40% | ― | -5.96% | ― |
iFabric Corp reported a record revenue of $9.0 million for Q3 2025, marking a 111% increase from the previous year, driven by strong demand for its technology-enhanced apparel. Despite a temporary dip in gross margins and earnings due to U.S. tariffs and ERP system rollout costs, the company remains optimistic about continued growth supported by a healthy order pipeline and retailer adoption. The company aims to maintain its upward trajectory by focusing on profitable execution and operational excellence.
iFabric Corp has secured a $2.5 million unsecured trade finance facility with Ebury Partners Canada Ltd. to enhance financial flexibility for growth and expansion. This facility, alongside an existing $12 million secured credit facility, is expected to support iFabric’s sales growth objectives and help manage foreign currency risks, reflecting a strategic move to strengthen its market position.
iFabric Corp’s subsidiary, IFTNA, has entered a licensing agreement with Mercury Athletics LLC to design, manufacture, and market scrubs and medical apparel under the Doctor’s Choice brand. This collaboration aims to integrate IFTNA’s textile technologies, including PROTX2®, to enhance infection-prevention and comfort in healthcare apparel, potentially strengthening iFabric’s position in the healthcare sector.
iFabric Corp. has announced the renewal of its license agreement with TUMI, Inc., allowing the continued integration of its PROTX2® antimicrobial solutions in select TUMI products for another five years. This partnership highlights the commitment of both companies to deliver performance, durability, and protection in travel essentials, with PROTX2 being featured in various TUMI collections, enhancing their product offerings with eco-friendly antimicrobial solutions.